InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Lebovits Chaim, Chairman & CEO. Director active across 1 companies, notably Brainstorm Cell Therapeutics INC.. In total, 2 disclosures have been published. The latest transaction was disclosed on 10 December 2021 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
031,185 shares0
Common Stock
SEC:0001104659-21-148753·
031,185 shares0
Common Stock
SEC:0001104659-21-148753:0·
2 of 2 declarations
About Lebovits Chaim
Chaim Lebovits is the Chief Executive Officer of Brainstorm Cell Therapeutics Inc. He plays a key role in leading the company, contributing to the research and development of innovative therapies. His expertise is essential for Brainstorm's growth.
